BOVNews – Finance | Market | Industry
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
What’s Causing Opendoor Technologies Inc (OPEN) Stock’s 3.29
2 days ago · BTIG Research has recently reduced Opendoor Technologies Inc (OPEN) stock to Neutral rating, as announced on December 20, 2023, according to Finviz.Earlier, on December 13, 2023, Keefe Bruyette had raised the stock from a Underperform to Mkt Perform, setting a price target of $3.50.
Why Citigroup Inc (C) Stock is Currently 3.21% Above from Its 20 …
2 days ago · Keefe Bruyette has recently raised Citigroup Inc (C) stock to Outperform rating, as announced on December 3, 2024, according to Finviz.Earlier, on April 4, 2024, Evercore ISI had reiterated their previous stock rating, setting a price target of $60 for C stock.
Boeing Co (BA) Stock: Analyzing Its Quiet Power – BOVNews
Nov 15, 2024 · Bernstein has recently reduced Boeing Co (BA) stock to Mkt Perform rating, as announced on October 30, 2024, according to Finviz. Earlier, on October 17, 2024, Bernstein had reiterated the stock to Outperform, setting a price target of $195 for BA stock. DZ Bank also reduced Hold rating with a price ...
Boeing Co (BA) Stock: More Strategic Than Meets the Eye
Oct 23, 2024 · Bernstein has recently reiterated Boeing Co (BA) stock to Outperform rating, as announced on October 17, 2024, according to Finviz.Earlier, on October 15, 2024, DZ Bank had reduced the stock from a Buy to Hold, setting a price target of $152.
BioVie Inc’s Stock Drama: Could This Be a Game-Changer for BIVI ...
Nov 12, 2024 · On Monday, BioVie Inc (BIVI) stock saw a modest uptick, ending the day at $2.99 which represents a slight increase of $0.24 or 8.73% from the prior close of $2.75. The stock opened at $2.76 and touched a low of $2.67 during the day, reaching a high of $3.08. The volume of shares traded was 4.22 ...
Nova’s (NVMI) Strategic Move: What’s Behind the Stock Surge?
Nov 29, 2024 · Nova’s YTD Performance: A Stellar Year Compared to the S&P 500. As of now, Nova’s stock has shown an impressive YTD performance of +34.35%, significantly outperforming the S&P 500, which has gained +26.63% over the same period. This gap in performance is a clear indication that Nova is thriving in its industry, as investors seem confident in the company’s growth prospects.
The Bowhead Specialty Holdings Inc Rollercoaster: What’s Behind …
Oct 25, 2024 · RBC Capital Mkts has recently initiated Bowhead Specialty Holdings Inc (BOW) stock to Outperform rating, as announced on June 17, 2024, according to Finviz.Earlier, on June 17, 2024, Morgan Stanley had initiated the stock research coverage, setting a price target of $26.
SGMO’s Latest Surge: What’s Behind the Spike? – BOVNews
Nov 4, 2024 · RBC Capital Mkts has recently reduced Sangamo Therapeutics Inc (SGMO) stock to Sector Perform rating, as announced on November 3, 2023, according to Finviz.Earlier, on April 28, 2023, BofA Securities had reduced the stock from a Neutral to Underperform, setting a price target of $1.50 for SGMO stock.
What’s Causing Iovance Biotherapeutics Inc (IOVA) Stock’s 4.05
5 days ago · UBS has recently initiated Iovance Biotherapeutics Inc (IOVA) stock to Buy rating, as announced on October 24, 2024, according to Finviz. Earlier, on July 29, 2024, Piper Sandler had reduced the stock from a Overweight to Neutral, setting a price target of $10 for IOVA stock. Goldman also initiated ...